Vor Biopharma Inc. (VOR)

Vor Biopharma Statistics

Total Valuation

Vor Biopharma has a market cap or net worth of $201.43 million. The enterprise value is $22.40 million.

Market Cap	201.43M
Enterprise Value	22.40M

Important Dates

The next estimated earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Vor Biopharma has 126.68 million shares outstanding. The number of shares has increased by 42.97% in one year.

Current Share Class	126.68M
Shares Outstanding	126.68M
Shares Change (YoY)	+42.97%
Shares Change (QoQ)	+0.36%
Owned by Insiders (%)	27.13%
Owned by Institutions (%)	12.41%
Float	52.66M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.49

Current Ratio	3.49
Quick Ratio	3.41
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-121.29%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-229.65%
Revenue Per Employee	n/a
Profits Per Employee	-$10.47M
Employee Count	159
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +56.18% in the last 52 weeks. The beta is 2.05, so Vor Biopharma's price volatility has been higher than the market average.

Beta (5Y)	2.05
52-Week Price Change	+56.18%
50-Day Moving Average	2.11
200-Day Moving Average	1.17
Relative Strength Index (RSI)	35.49
Average Volume (20 Days)	4,263,188

Short Selling Information

The latest short interest is 19.78 million, so 15.62% of the outstanding shares have been sold short.

Short Interest	19.78M
Short Previous Month	18.41M
Short % of Shares Out	15.62%
Short % of Float	37.57%
Short Ratio (days to cover)	4.26

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-336.67M
Pretax Income	-118.09M
Net Income	-1.66B
EBITDA	-332.09M
EBIT	-336.67M
Earnings Per Share (EPS)	-$17.13

Balance Sheet

The company has $200.57 million in cash and n/a in debt, giving a net cash position of $200.57 million or $1.58 per share.

Cash & Cash Equivalents	200.57M
Total Debt	n/a
Net Cash	200.57M
Net Cash Per Share	$1.58
Equity (Book Value)	-1.51B
Book Value Per Share	-11.98
Working Capital	146.15M

Cash Flow

In the last 12 months, operating cash flow was -$113.60 million and capital expenditures -$489,000, giving a free cash flow of -$114.09 million.

Operating Cash Flow	-113.60M
Capital Expenditures	-489,000
Free Cash Flow	-114.09M
FCF Per Share	-$0.90

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Vor Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-42.97%
Shareholder Yield	-42.97%
Earnings Yield	-746.51%
FCF Yield	-51.17%

Analyst Forecast

The average price target for Vor Biopharma is $3.90, which is 145.28% higher than the current price. The consensus rating is "Buy".

Price Target	$3.90
Price Target Difference	145.28%
Analyst Consensus	Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1